Albert Bourla
Chairman & CEO of Pfizer Inc. (2019–Present)
Albert Bourla has served as Chairman & CEO of Pfizer Inc. for 7 years 10 months (2,873 days), holding office continuously since Jan 1, 2019. At present, Albert Bourla ranks as the #55 longest-serving chief executive among tracked leaders in the database.
Executive Succession & Corporate Facts
- Predecessor
- Not recorded
- Successor
- Active (Currently serving in office)
- Database Tenure Rank
- #55 Longest-Serving CEO in Database (View Full Rankings →)
- Company Founded
- Jan 1, 1849 (New York, New York)
- Known Aliases
- None recorded
Tenure Milestones & Transition Timeline
Dr. Albert Bourla Elected Chief Executive Officer of Pfizer
Pfizer's Board elected COO Albert Bourla to succeed Ian Read as CEO effective January 1, 2019.
Dr. Albert Bourla Formally Takes Office as Pfizer CEO
Bourla assumed leadership, pivoting Pfizer into a science-driven biopharmaceutical innovator and separating the Upjohn off-patent business.
Pfizer and BioNTech Announce Landmark Vaccine Trial Demonstrating Over 90% Efficacy
Bourla announced unprecedented Phase 3 clinical trial results for the BNT162b2 mRNA vaccine candidate against COVID-19.
Pfizer Completes $43 Billion Acquisition of Seagen to Expand Oncology Leadership
Bourla closed Pfizer's acquisition of antibody-drug conjugate pioneer Seagen, doubling Pfizer's clinical oncology pipeline.
Related Leaders & Rankings
Primary verified disclosure and leadership profile.
Compare tenure duration against currently active corporate leaders.
Compare against all 80 permanent executives in our database.